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Abstract 
In yeasts, small intrinsically disordered proteins (IDPs) modulate ribonucleotide reductase (RNR) 
activity to ensure an optimal supply of dNTPs for DNA synthesis. The S. pombe Spd1 protein can 
directly inhibit the large RNR subunit (R1), import the small subunit (R2) into the nucleus and 
induce an architectural change in the R1-R2 holocomplex. Here, we report the characterization of 
Spd2, a protein with homology to Spd1. We show that Spd2 is a CRL4Cdt2 controlled IDP that 
functions together with Spd1 in the DNA damage response and in modulation of RNR architecture. 
However, Spd2 does not regulate dNTP pools and R2 nuclear import. Furthermore, deletion of spd2 
only weakly suppresses the Rad3ATR checkpoint dependency of CRL4Cdt2 mutants. However, when 
we raised intracellular dNTP pools by inactivation of RNR feedback inhibition, deletion of spd2 
could suppress the checkpoint dependency of CRL4Cdt2 mutant cells to the same extent as spd1. 
Collectively, these observations suggest that Spd1 on its own regulates dNTP pools, while it 
together with Spd2 modulates RNR architecture and sensitizes cells to DNA damage. 
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Introduction 
Correct regulation of DNA building block levels is emerging as a pre-requisite for the maintenance 
of genome integrity. Cancer development is presumed to be initiated by oncogenic mutations that 
cause replication stress, thereby increasing the risk of replication fork collapse and subsequent 
formation of DNA lesions (Halazonetis et al., 2008). This type of oncogenic replication stress has 
been reported to be accompanied by a significant reduction in cellular deoxynucleoside triphosphate 
(dNTP) pools, possibly due to an imbalance between nucleotide synthesis and DNA replication 
activity (Beck et al., 2012; Bester et al., 2011) . Furthermore, such oncogenic S phase problems, 
including shorter inter origin distances and slower fork migration, can be reversed by an exogenous 
supply of nucleosides, suggesting that insufficient levels of DNA building blocks may play an 
important causal role in early stages of tumour development. 
  The rate-limiting step in dNTP production is catalysed by the essential and highly conserved 
enzyme ribonucleotide reductase (RNR), which reduces ribonucleoside diphosphates to their 
corresponding deoxy forms. Eukaryotic cells utilize class 1a RNR, a heteromeric enzyme consisting 
of up to three copies of two different dimeric subunits, R1 and R2. The catalytic activity resides in 
the large R1 subunit, while the smaller R2 subunit donates reducing power to the reaction from a 
diferric tyrosyl radical (Nordlund and Reichard, 2006).   
  Consistent with deoxynucleotide pools being important for maintenance of genome integrity, 
cellular RNR function is tightly regulated at several levels. Expression of both subunits is induced 
under conditions where DNA synthesis is required, i. e. in S phase or after DNA damage (Elledge et 
al., 1993). Furthermore, the activity of RNR is regulated by two intricate feedback control 
mechanisms (Reichard, 2010). The R1 subunit contains two allosteric effector binding sites, the 
specificity site (S site) and the activity site (A site). The S site ensures a balanced supply of the four 
DNA building blocks, by binding dNDP species present in excess thereby remodeling the catalytic 
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site towards other base substrates. The A site represents a molecular switch that regulates the 
overall activity of the enzyme by monitoring the cellular dATP/ATP ratio: RNR is inactive when 
dATP is bound, and it becomes activated when dATP is replaced by ATP. Recent structural studies 
suggest that the inactive form of the enzyme is a hexameric ring consisting of three R1 dimers with 
an R2 dimer embedded in the middle (Fairman et al., 2011). Less is known about the structure of 
the active, ATP bound form, but the molecular interaction between the R1 and R2 subunits appears 
to be altered relative to the dATP bound complex, and it may contain additional R2 dimers (Hofer 
et al., 2012). RNR can be locked genetically in its active configuration by replacing Asp 57 in the A 
site with Asn. Mammalian cell lines harbouring this D57N mutated version of R1 have highly 
increased dNTP pools indicating that a large proportion of RNR complexes normally is in the 
inhibited form in vivo (Weinberg et al., 1981).   
  In yeasts, RNR activity is additionally regulated by a group of small intrinsically disordered 
proteins (IDPs). In fission yeast, the Spd1 protein can inhibit RNR by two different mechanisms. It 
can sequester the R2 subunit in the nucleus, away from the R1 subunit which is mainly cytosolic 
(Liu et al., 2003), and it can also directly bind to and inhibit the R1 subunit (Hakansson et al., 
2006). We recently reported that Spd1 can modulate the RNR complex in yet a third fashion: If the 
R1 and R2 subunits are tagged with different fluorescent proteins, a fluorescence resonance energy 
transfer (FRET) reaction can be observed between them, and this signal is absent in Δspd1 cells 
(Nestoras et al., 2010). It is unclear how the underlying Spd1-mediated change in the molecular 
interactions between R1 and R2 affects RNR function. Interestingly, these three molecular functions 
of Spd1 can be separated genetically, suggesting that the protein mediates them by different 
molecular mechanisms (Nestoras et al., 2010). 
  The limited sequence conservation of RNR inhibitory IDPs has thus far precluded resolving the 
issue of whether mammalian counterparts exist. However, in the distantly related budding yeast S. 
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cerevisiae, two Spd1-related IDPs, Dif1 and Sml1, sequester R2 in the nucleus or inhibit R1, 
respectively. Interestingly, synteny analysis suggests that these two genes arose through genome 
duplication of a common ancestor with both functions, similar to S. pombe Spd1 (Lee et al., 2008). 
A third potential Spd1-related protein, Hug1, is also predicted in the budding yeast genome, but no 
function has yet been assigned to this  (Basrai et al., 1999). 
  When fission yeast cells undergo DNA replication or repair, the Spd1 protein becomes degraded 
by CRL4Cdt2 mediated ubiquitylation (Holmberg et al., 2005; Liu et al., 2003), a process that is 
mediated on chromatin-associated PCNA (Salguero et al., 2012), and also requires the Csn1 and 
Csn2 subunits of the COP9/signalosome (Liu et al., 2003). The CRL4Cdt2 E3 ubiquitin ligase is 
activated by transcriptional induction of the Cdt2 substrate adaptor, which becomes expressed in 
unperturbed S phase by the MCB transcription complex.  Following DNA damage, Cdt2 is induced 
by a Rad3ATR-dependent pathway (Liu et al., 2005; Moss et al., 2010).  
  CRL4Cdt2 defective cells undergo DNA replication in the presence of Spd1, and this gives rise to 
severe S-phase stress: replication proceeds slowly, with concomitant activation of the Rad3ATR 
checkpoint, which becomes essential for cell survival under these conditions. Furthermore, such 
cells are hypersensitive to DNA damaging agents, are defective in double-strand break (DSB) repair 
by homologous recombination, display a more than 20 fold increase in spontaneous mutation rates, 
and are also completely unable to undergo pre-meiotic S phase (Holmberg et al., 2005; Liu et al., 
2005; Liu et al., 2003; Moss et al., 2010). The requirement for a functional Rad3ATR pathway and 
the defects in recombination and pre-meiotic S-phase are all fully reversed by deletion of the spd1 
gene or by overexpression of fission yeast R2 (Suc22R2), suggesting that these phenotypes are 
caused by Spd1-mediated RNR inhibition. On the other hand, the increased mutation rates and 
sensitivity to DNA damage are only partially suppressed by Spd1 loss, indicating that deregulation 
of other CRL4Cdt2-controlled processes also contributes to these phenotypes.   
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  The systematic genetic analysis of spd1 has shown that certain mutants defective in nuclear import 
of the RNR R2 subunit or in the FRET reaction between R1 and R2 still require the Rad3ATR 
pathway for survival when the Spd1 degradation pathway is inactivated (Nestoras et al., 2010).  
These observations are consistent with a model where Spd1 causes checkpoint activation by 
inhibiting dNTP formation via direct binding to RNR. However, we recently reported that Spd1 
accumulation can cause checkpoint activation even in cells that have highly elevated dNTP pools 
due to inactivation of RNR feedback inhibition (Fleck et al., 2013). Hence, Spd1 may also cause 
checkpoint activation independently of deoxynucleotide synthesis. 
  In the present study we have characterized Spd2, an Spd1-related putative RNR inhibitor that was 
identified in a comparative genome sequencing study (Rhind et al., 2011). We show that Spd2, 
similar to Spd1, is an IDP that becomes degraded by CRL4Cdt2 ubiquitylation following inhibition 
of RNR by hydroxyurea. Similar to Δspd1, deletion of spd2 can  rescue the damage sensitivity of 
CRL4Cdt2 mutants, and Spd2 - like Spd1 - is required for the FRET signal between R1 and R2. 
However, Spd2 does not share the ability of Spd1 to sequester the R2 subunit in the nucleus, and – 
surprisingly – it does not seem to affect cellular dNTP pools. These observations support a model 
where Spd2 can assist Spd1 in an S phase inhibitory pathway that functions independently of dNTP 
formation. 
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Results 
Spd2 – a new RNR inhibitor homolog 
The genomes of four Schizosaccharomyces species have recently been sequenced (Rhind et al., 
2011). The availability of the sequences of three additional fission yeast species allowed the 
identification of more than 100 new conserved open reading frames in the S. pombe genome. One of 
these proteins, Spd2, shows limited homology to Spd1 (19% overall sequence identity) and other 
RNR inhibitors (Figure 1). 
  In general, the homology among RNR inhibitors is limited to a number of short motifs. The Spd1 
and Spd2 orthologues also appear to have diverged considerably, but are very well conserved within 
the Spd1 and Spd2 subgroups (Figure 1A). The Spd1 and Spd2 families share a small domain near 
their C-terminal ends, which is absent in the other known RNR inhibitors. We will refer to this as 
the Spd domain (Figure 1B). 
  The Spd1 and Spd2 orthologues of the four fission yeast species all contain a Hug domain (Figure 
1A), which is also present in the S. cerevisiae Hug1 and Dif1 proteins and in Ashbya gossypii 
Aer122c, but absent in budding yeast Sml1 (Figure 1B). The Hug domain of Dif1 is required for 
nuclear import of the small RNR subunit (Lee et al., 2008; Wu and Huang, 2008), and genetic 
analysis suggests that the Hug domain of Spd1 may have a similar function (Nestoras et al., 2010). 
The N-terminal part of the Hug domain in Spd1 was recently shown to constitute a PIP (PCNA 
interacting protein) degron, mediating binding to PCNA, which is a prerequisite for CRL4Cdt2-
dependent ubiquitylation and subsequent degradation of Spd1 (Salguero et al., 2012). This motif is 
present in Spd2 (Figure 1), suggesting that the protein is degraded by a similar mechanism (see 
below).  
  The CRL4Cdt2 degradation pathway is absent in budding yeast. Instead, degradation of Sml1 and 
Dif1 during S phase or in response to DNA damage is triggered by Dun1-mediated phosphorylation 
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of a phospho-degron referred to as the Sml1 domain (Lee et al., 2008; Uchiki et al., 2004; Wu and 
Huang, 2008; Zhao and Rothstein, 2002). Consistent with a different degradation mechanism in 
fission yeast, this Sml1-degron is absent in both Spd1 and Spd2 (Figure 1B). 
  Finally, Sml1 can bind to and inhibit the large RNR subunit through its Rnr1 domain (Zhao et al., 
2000). Although it has been shown that S. pombe Spd1 also can bind to the large RNR subunit 
(Hakansson et al., 2006), conservation of the Rnr1 domain in Spd1 is limited to a short stretch of 
amino acid residues. In Spd2, the homology to the Rnr1 domain is even more limited, if not absent 
(Figure 1B).  
 
Spd2 is an intrinsically disordered protein 
Similar to Spd1 and Sml1 (Danielsson et al., 2008; Nestoras et al., 2010), the sequence of Spd2 has 
the typical characteristics of an IDP: a high content of charged residues (29%) and a low aliphatic 
index (67.94; for reference, myoglobin = 95.1). These proteins lack well-structured three-
dimensional folds and are distinctive by having regions that form lowly populated, transient 
structures and/or contain conserved sequence motifs (Tompa, 2002). Importantly, these local 
features are central to target recognition and the flexibility of the IDPs is essential for binding to 
more than one partner. To investigate the disorder characteristics of Spd2 by spectroscopy, 
recombinant Spd2 was produced in E. coli and purified to > 98% homogeneity (Figure 2A). A far-
UV CD spectrum of Spd2 showed no signs of pronounced secondary structure elements, with little 
negative ellipticity in the 210-220 nm range (Figure 2B). Instead, a large negative ellipticity with 
maximum at 199 nm suggested a disordered protein with little or no secondary structure. In support 
of this, an 15N,1H-HSQC NMR spectrum of 15N-labeled Spd2 recorded at 10 °C showed a narrow 
dispersion of signals in the 1H- dimension, further suggesting that the protein is disordered with no 
globular fold (Figure 2C). Unlike Spd1, the peaks of the NMR spectrum of Spd2 were of almost 
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equal intensity, revealing the higher solubility of this protein compared to Spd1 (Nestoras et al., 
2010) and (data not shown). Thus, Spd2 possesses hallmarks of an IDP (Tompa, 2002) with low-
complexity sequence, a lack of secondary structure elements in a far-UV CD spectrum and a 
collapsed NMR spectrum.  
 
Spd1 and Spd2 both inhibit S phase  
  We next constructed a strain deleted for the spd2 gene. Similarly to Δspd1 cells, this ∆spd2 strain 
showed no obvious phenotypic differences to wild type regarding cell shape and growth rate (data 
not shown). Spd1 was originally identified as a protein that inhibited S-phase progression when 
over-expressed, thereby causing cell elongation (Woollard et al., 1996). We found that 
overexpression of Spd2 similarly caused cell elongation (Figure 3A). Elongation of cells by 
overexpression of Spd2 did not require functional Spd1 and vice versa.  
  Next, we used flow cytometry (FACS) to monitor the cell-cycle distribution in cells 
overexpressing Spd1 or Spd2. Interpretation of FACS data in fission yeast is complicated by the 
fact that G1 and S phase cells are still attached to their sisters, thus giving rise to a 2C signal. 
However, by measuring the DNA signal width, it is possible to discriminate G1 and S cells from G2 
cells (Knutsen et al., 2011), thus giving a more precise estimate of the S-phase population. By this 
method we found that overexpression of Spd2 caused a strong increase in the number of cells 
undergoing S phase, suggesting that the protein - similarly to Spd1 - delays DNA replication 
(Figure 3B + Suppl. Figure S1). Again, Spd1 and Spd2 could cause this phenotype independently of 
each other. 
 
Spd2 is a CRL4Cdt2 target 
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Spd1 is a target of the CRL4Cdt2 E3 ubiquitin ligase (Holmberg et al., 2005; Liu et al., 2005; Liu et 
al., 2003), and we next investigated if this was also the case for Spd2. Since we found that epitope 
tagging of Spd1 adversely affected its functionality (data not shown), we raised antibodies against 
recombinant Spd1 and Spd2 proteins. Similar to Spd1, Spd2 was degraded in response to HU 
treatment and this response was completely abolished in CRL4Cdt2 defective ∆ddb1 cells, where the 
steady state level of Spd2 was also higher than in wild type (Figure 4A). Furthermore, deletion of 
spd2 suppressed the elongated cell phenotype and improved the growth rate of CRL4Cdt2 defective 
Δddb1 cells to approximately the same extent as spd1 deletion (data not shown). Hence, consistent 
with the presence of a PIP degron in the protein (Figure 1A), we conclude that Spd2 - like Spd1 - is 
a target for CRL4Cdt2 mediated ubiquitylation 
  Degradation of Spd2 appeared to be independent of Spd1 and vice versa (Figure 4A+C). Deletion 
of spd2 apparently caused a modestly elevated Spd1 level in asynchronously growing cells (Figure 
4C). Consistent with this, we found that spd1 mRNA levels were 1.5 fold increased in exponentially 
growing ∆spd2 cells compared to wild type (Supplemental Figure S2). 
  Spd1 becomes degraded as cells enter S phase, because the CRL4 substrate adaptor Cdt2 is 
controlled by the S phase-specific transcription complex MCB (Liu et al., 2005). We synchronized 
wild-type cells by centrifugal elutriation and monitored the levels of Spd1 and Spd2 as cells 
progressed through S phase (Figure 4B). As observed previously (Liu et al., 2003), Spd1 became 
down-regulated as cells entered S phase, but for Spd2, we could not detect a similar robust 
reduction.  
 
Spd2 functions in the damage response 
  CRL4Cdt2 defective cells are sensitive to the RNR inhibitor hydroxyurea (HU) and the DNA 
alkylating agent methyl methane sulphonate (MMS) (Holmberg et al., 2005; Zolezzi et al., 2002), 
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and this phenotype can be partially suppressed by concomitantly deleting the spd1 gene, suggesting 
that accumulation of excess Spd1 protein contributes to the observed drug sensitivity. We therefore 
investigated whether deletion of the spd2 gene could also affect the damage sensitivity of CRL4Cdt2 
defective Δddb1 cells. Rescue of the MMS sensitivity of ∆ddb1 occurred to a similar modest extent 
in both ∆ddb1 ∆spd1 and ∆ddb1 ∆spd2 double mutants and there was no further suppression in the 
∆ddb1 ∆spd1 ∆spd2 triple mutant. However, the observed suppression was too weak to draw firm 
conclusions on the epistatic relationship between spd1 and spd2 (Figure 5A). We also tested for 
sensitivity to the DSB inducing agent zeocin. Similar to spd1, deletion of spd2 could rescue the 
sensitivity of Δddb1 cells. However, deletion of spd1 on its own conferred almost complete 
suppression, again making it difficult to evaluate epistasis (Figure 5A).  
  When deleting spd2, the HU sensitivity of Δddb1 cells could be suppressed to almost the same 
extent as when deleting spd1, and when both genes were deleted, we saw increased rescue (Figure 
5B). Thus, spd1 and spd2 can have both overlapping and separate functions in the damage 
sensitivity conferred by CRL4Cdt2 inactivation.  
 
Spd2 is required for Cdc22R1-Suc22R2 FRET 
When the small and large RNR subunits are tagged with two different fluorescent proteins, a FRET 
signal can be observed in wild-type cells (Nestoras et al., 2010). The underlying molecular 
mechanism for this signal is not clear, but since it is absent in cells not expressing Spd1, it 
presumably represents an Spd1-dependent remodelling of RNR complex architecture that brings the 
two fluorescent proteins in closer proximity. We analysed whether FRET was also dependent on 
Spd2 and found that this was indeed the case: in both the nucleus and cytoplasm, the FRET signal 
was lost in a Δspd2 strain (Figure 6A+B). Thus, both Spd1 and Spd2 promote the architectural 
change in RNR structure that is manifested by the FRET signal between Cdc22R1 and Suc22R2.  
11 
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 Spd2 is not required for Suc22R2 nuclear import 
Spd1 regulates nuclear import of the small RNR subunit Suc22R2 (Liu et al., 2003). In wild-type 
cells, Suc22R2 accumulates in the nucleus, while it becomes largely cytosolic in ∆spd1 mutant cells, 
and upon HU-induced degradation of Spd1, Suc22R2 redistributes to the cytosol (Liu et al., 2003; 
Nestoras et al., 2010). Since the Cdc22R1 subunit is mainly cytosolic, this nuclear export of Suc22R2 
has been proposed to cause formation of an increased number of active RNR complexes (Liu et al., 
2003; Nielsen, 2003). We found that Suc22R2 nuclear localization was lost in Δspd1 cells but 
unchanged in ∆spd2 cells (Figure 6C). Thus, nuclear import of Suc22R2 clearly constitutes an Spd1 
function not shared by Spd2. 
 
Spd2 accumulation partially inhibits meiosis 
Cells defective in the CRL4Cdt2 E3 ubiquitin ligase are unable to undergo meiosis, and this defect 
can be suppressed by concomitantly deleting the spd1 gene (Holmberg et al., 2005; Nestoras et al., 
2010; Yoshida et al., 2003). We therefore tested the effect of deleting spd2 on meiotic competence 
of the CRL4Cdt2 mutants ∆ddb1, ∆csn1, and ∆cdt2 (Figure 7A). The majority of zygotes of all three 
homothallic CRL4Cdt2 mutants could not develop spores (~80-90%; Figure 7A), consistent with 
previous data, and these defects were suppressed to almost wild-type levels by deletion of spd1 
(~85-90% asci with 4 spores versus 97% in wild type). In contrast, deleting spd2 in these CRL4Cdt2 
mutant backgrounds only partially rescued meiosis. Besides empty zygotes (~50%), asci with two 
spores (~30%) were predominantly formed (Figure 7A,B). A ∆ddb1 ∆spd2 ∆spd1 triple mutant 
underwent meiosis as efficiently as a ∆ddb1 ∆spd1 double mutant (~90% 4-spored asci for both 
strains). Hence, Spd2 has an inhibitory function during meiosis. However, in contrast to Spd1, 
meiosis of the CRL4Cdt2 mutants was still partially inhibited in the absence of Spd2.  
12 
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 Spd2 accumulation plays a role in checkpoint activation but does not affect dNTP levels 
CRL4Cdt2 defective cells rely on activation of the Rad3ATR checkpoint for viability and this 
phenotype is suppressed by deletion of the spd1 gene (Holmberg et al., 2005; Liu et al., 2003; 
Nestoras et al., 2010), suggesting that Spd1 accumulation is the major cause of checkpoint 
activation. We confirmed that CRL4Cdt2 defective ∆ddb1 and ∆csn1 cells carrying a temperature 
sensitive rad3 allele died at the restrictive temperature, and that their viability was largely restored 
by elimination of the spd1 gene (Figure 7C). When deleting spd2 in rad3-TS ∆ddb1 or rad3-TS 
∆csn1 backgrounds, we also observed rescue of viability, albeit only partially (Figure 7C). 
Simultaneous deletion of spd1 and spd2 fully restored viability to a level above the spd1 deletion, 
suggesting that accumulation of the two proteins can cause checkpoint activation independently of 
each other (Figure 7C). Thus, Spd1 is the major CRL4Cdt2 target causing Rad3ATR dependency, 
while the contribution from Spd2 appears to be modest. 
  Presumably, checkpoint activation triggered by Spd1 accumulation is signalled by replication 
stress involving single stranded DNA formation caused by RNR inhibition and possibly also by 
interference with PCNA, the other known interaction partner of Spd1 (Holmberg and Nielsen, 2012; 
Moss et al., 2010; Salguero et al., 2012; Fleck et al., 2013). We found that ∆spd2 cells – unlike 
Δspd1 cells - did not have elevated dNTP pools (Figure 7D). Hence, the modest checkpoint 
dependency caused by Spd2 accumulation appears to be unrelated to repression of dNTP pools. 
 
Elevated dNTP pools enhance ∆spd2-dependent suppression of CRL4Cdt2 defects 
 The results reported thus far in this paper demonstrate that Spd2 shares some but not all functions 
with Spd1. In particular, overall cellular dNTP pools appear to be repressed by Spd1 but not by 
Spd2, and we speculated that this difference may explain why - for certain phenotypes - we 
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observed a weaker rescue of CRL4Cdt2 defective cells when deleting spd2 as opposed to spd1. In 
other words, Spd1-mediated repression of deoxynucleotide pools may still obscure the effect of 
deleting spd2. To test this hypothesis, we monitored the effect of deleting spd2 in CRL4Cdt2 
defective cells that had their dNTP pools up-regulated independently of Spd1. In order to do this, 
we utilized the cdc22D57N mutant, which causes elevated dNTP pools because the dATP feedback 
inhibition of RNR is abolished (Chabes et al., 2003; Fleck et al., 2013). Importantly, CRL4Cdt2 
compromised ∆ddb1 cdc22D57N cells have higher dNTP levels than wild-type (Fleck et al., 2013). 
Interestingly, homothallic ∆ddb1 ∆spd2 cdc22D57N triple mutant cells sporulated at a level 
comparable to ∆ddb1 ∆spd1 cells and much better than the corresponding ∆ddb1 ∆spd2 and ∆ddb1 
cdc22D57N double mutant cells (Figure 8A). Similarly, the combination of ∆spd2 and cdc22D57N 
allowed growth of rad3-TS ∆ddb1 at the restrictive temperature to the same extent as ∆spd1, and 
much better than either ∆spd2 or cdc22D57N alone (Figure 8B). These results confirm that Spd2 
shares certain functions with Spd1, and are consistent with a model where these shared functions do 
not include Spd1’s control over dNTP levels. 
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Discussion 
The fission yeast Spd1 protein has attracted considerable interest because of its impact on genome 
integrity, but its biological function remains enigmatic. Strikingly, most of our knowledge of Spd1 
function comes from studies of cells that artificially over-accumulate Spd1 – either through ectopic 
expression of the gene or via inactivation of its CRL4Cdt2 degradation pathway. In general, the 
phenotypes associated with loss of Spd1 function seem quite harmless to the cell. In fact, 
elimination of Spd1 often improves growth or survival under conditions that challenge genome 
integrity.   
  Spd1 inhibits S phase and becomes degraded when cells embark on DNA synthesis. Its function 
includes a negative effect on deoxynucleotide formation when DNA replication is not ongoing, but 
perhaps the protein also plays more dynamic roles in preventing damage to the genome (Holmberg 
and Nielsen, 2012; Fleck et al., 2013). 
  In this report we have characterized the Spd1-related protein Spd2. We have shown that Spd2 -
similar to Spd1 - is a CRL4Cdt2-targeted IDP that inhibits DNA replication and modulates RNR 
structure. Curiously, Spd2 appears to participate only in a subset of Spd1 controlled processes. It 
seems to be required neither for nuclear import of RNR R2 nor for repression of deoxynucleotide 
pool levels. Furthermore, the relationship between Spd1 and Spd2 is complex. Both proteins can 
inhibit S-phase independently of each other when over-accumulating, but for the architectural 
remodelling of RNR (as manifested by the FRET assay) they seem to cooperate. According to a 
recent quantitative expression study, Spd1 and Spd2 are present at similar levels in the cell 
(respectively, ~14,000 and ~16,000 molecules/cell, Marguerat et al., 2012), so their different 
behaviour seems to be caused by different functions rather than different concentrations. 
  CRL4Cdt2 defective cells constitutively activate their Rad3ATR checkpoint, presumably because 
Spd1 reduces dNTP pools and interferes with other so far uncharacterized functions important for 
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genome integrity (see below). Thus, in accordance with previous reports (Holmberg et al., 2005; 
Liu et al., 2003; Nestoras et al., 2010), we found that the viability of CRL4Cdt2 defective rad3-TS 
cells was restored by deleting the spd1 gene (Figure 7C). However, deletion of spd2 only caused an 
intermediate suppression of viability in this assay. Hence, accumulation of Spd2 appears to make 
cells much less dependent on the Rad3ATR checkpoint pathway for survival than Spd1 accumulation. 
Furthermore, since simultaneous deletion of spd1 and spd2 caused enhanced suppression (Figure 
7C), the two proteins appear to activate the checkpoint independently of each other. 
  Unlike Spd1, Spd2 is not required for nuclear import of Suc22R2. Analogous to the S. cerevisiae 
Dif1 protein, genetic analysis suggests that the Hug domain of Spd1 is required for nuclear import 
of Suc22R2 (Nestoras et al., 2010). The Hug domain is well conserved in Spd2 (Figure 1), so the 
fact that Spd2 is dispensable for Suc22R2 nuclear import suggests that other regions in Spd1 are also 
needed. Consistent with this, mutant spd1-m2 (replacing amino acids K5, R6 and V7 with alanines) 
was reported also to be defective in Suc22R2 nuclear import (Nestoras et al., 2010). This region is 
absent in Spd2 (Figure 1A). The biological relevance of Spd1-mediated nuclear Suc22R2 import is 
not yet known, but genetically this function can be separated from checkpoint activation (Nestoras 
et al., 2010). 
  Both Spd1 and Spd2 become degraded in a CRL4Cdt2 dependent reaction, when RNR is inhibited 
by HU (Figure 4A+C). Ubiquitylation of CRL4Cdt2 target proteins requires binding to DNA-
associated PCNA, so in principle Spd1 and Spd2 should also both be down-regulated when Cdt2 is 
induced at S phase. However, unlike the situation for Spd1, we did not observed a robust down-
regulation of Spd2 during unperturbed S phase (Figure 4B).  
  While Spd1 on its own appears to control deoxynucleotide pools and Suc22R2 nuclear import, it 
mediates the conformational change in RNR complexes (reflected by the FRET signal) together 
with Spd2. In our assays for checkpoint dependency and meiotic competence, we found that some 
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inhibitory function remained in the Δspd2 CRL4Cdt2 mutant backgrounds (Figure 7A+C). We 
reckoned that this might be due to inhibition of dNTP formation by accumulated Spd1 protein. 
Hence, we introduced the cdc22D57N mutation into these backgrounds. This mutation abolishes the 
allosteric feedback inhibition of RNR and elevates the dNTP pools to a level well above that 
obtained by deleting spd1 (Fleck et al., 2013). Interestingly, on their own both the cdc22D57N 
mutation and Δspd2 could partially rescue the checkpoint requirement and meiotic defect of 
CRL4Cdt2 mutated cells. However, when combined, we saw a better suppression in both assays, 
similar to the effect obtained by deleting spd1 (Figure 8A+B). Therefore, an important conclusion 
of the present study is that excess Spd1can cause checkpoint activation by both deoxynucleoside 
dependent and independent mechanisms, and only the latter seems to require Spd2. In accordance 
with this, we recently reported that Spd1 accumulation can cause checkpoint activation even in cells 
that have elevated dNTP pools due the cdc22-D57N mutation (Fleck et al., 2013). 
  A key unanswered question is how Spd1 and Spd2 can cause checkpoint activation independently 
of deoxynucleotide regulation. Currently, the only known mutual Spd1-Spd2 function is the 
conformational change in RNR architecture manifested by the FRET assay. Hence, a molecular 
characterization of the RNR FRET phenomenon is highly important for understanding how small 
IDP proteins like Spd1 and Spd2 regulate genome integrity. Equally important, particularly from a 
cancer perspective, is the issue of whether this complex yet fascinating group of proteins also exists 
in human cells.  
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Materials and Methods 
Strains and media 
Strain construction and growth media were applied according to standard genetic techniques for S. 
pombe (Moreno et al., 1991). A list of strains used in this study is included as Supplemental Table 
S1. Δspd2 was constructed as follows: A PCR reaction was performed with the pFA6a-kanMX 
plasmid (Bahler et al., 1998) as template and the primer set ONP687 + ONP688 
(GATACTTTTTAATTGTTTTACTTATCCAGGCGCCAGCTGAAGCTTCGTAC + 
TCGAAAGCTTTATCTTGCTCATTTATTCATGGCCACTAGTGGATCTGATA), two additional 
PCR reactions were performed with purified genomic S. pombe DNA and the primer sets ONP689 
+ ONP690 (ATGAATAAATGAGCAAGATAAAGCTTTCGA + 
AGTAACTTTCGACACATTCAAATGGTGT) and ONP691 + ONP692 
(CCTGGATAAGTAAAACAATTAAAAAGTATC + 
ACGACTTGAAGCTTACTCGCTTCTAAAAGG). The three PCR products were used for a fusion 
PCR with ONP690 + ONP692 and the resulting amplicon was used for transformation of Eg432. 
G418 resistant clones were selected, positive clones were checked for correct recombination of the 
PCR product and a resulting strain was designated Eg2806 and used for subsequent studies. 
  Plasmids for overexpression of Spd1 (pON736) or Spd2 (pON1126) from the thiamine-repressible 
nmt1 promoter were obtained by cloning the ORFs into pREP3 (Maundrell, 1990).   
 
FACS 
Cells were fixed as described by (Kjaerulff et al., 2005), and stained with Sytox Green (Molecular 
Probes) as recommended by the manufacturer. Quantification of S phase cells with the aid of the 
DNA signal width was according to (Knutsen et al., 2011). For each sample, a total of 30,000 cells 
were counted, and after gating at least 75 % were still present.  
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 Sensitivity assays 
5-fold dilution series of the indicated strains were spotted onto YEA plates containing the indicated 
drugs. Plates were cast 2 days prior to use and kept at room temperature. Pictures were taken after 3 
days of incubation at 33°C (or indicated temperature). 
 
Structural analysis 
The Spd2 ORF was ligated into a pET11a plasmid and expressed in BL21(DE3) cells grown in 1 L 
LB media to OD600 0.7-0.8 and induced by 0.01 mM IPTG for 3 hours at 37°C. Purification of Spd1 
and Spd2 and structural analyses of Spd2 were performed essentially as in (Nestoras et al., 2010). 
The far-UV CD spectrum of Spd2 was recorded from 250 to 190 nm on 10 μM Spd2 and 10 mM 
NaH2PO4 (pH 7.4) subtracting the corresponding buffer spectrum. The 15N, 1H-HSQC NMR 
spectrum was recorded on 277 μM 15N-Spd2, 100 mM NaCl and 10 mM NaH2PO4 (pH 7.4) at 10 
°C. 
 
Western blots 
Cultures were grown to midlog phase at 30°C in YE and 5×107 cells were harvested. All samples 
were TCA extracted and run on 15% SDS-PAGE gels and wet-blotted (300 mA) for 1.5 hours at 
4°C. After blocking, membranes were incubated ON at 4°C with the indicated primary antibodies. 
To study protein levels in response to HU treatment, cultures were grown to midlog phase and 
5×107 cells were harvested, 20mM HU were added to the remainder of the cultures and after 4 
hours, 5×107 cells were harvested. To analyse synchronous populations, 6 litres of culture was 
grown to midlog phase and cells were size sorted by elutriation. The smallest sized cells were 
collected at a concentration of approx. 2×106 cells/ml and incubated at 30°C. 1×108 cells were 
19 
 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
harvested at each of the indicated time points. Polyclonal rabbit α-Spd1 and α-Spd2 antibodies were 
raised against E. coli purified proteins by Yorkshire Bioscience Limited. 
 
Cell biology 
Suc22-GFP localisation assay and FRET analysis of the Cdc22/Suc22 FRET-pair were performed 
as previously described (Nestoras et al., 2010). For meiotic analysis, h90 strains of the indicated 
genotypes were spotted onto solid sporulation medium at 25°C and after three days the number of 
spores (0 through 4) in at least 100 individual zygotes/asci were counted.  
 
dNTP pools 
dNTP measurement were performed as described (Beck et al., 2012) and the levels were normalized 
to ATP. For normalization, the dNTP/ATP ratio was set to 1 in the wild type. 
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Figure legends 
Figure 1. Spd2 is homologous to Spd1 and other known RNR inhibitors. (A) Comparison of amino 
acid sequences of Spd1 and Spd2 orthologues of the four Schizosacchomyces species S. pombe 
(Spo), S. cryophilus (Scr), S. octosporus (Soc), and S. japonicus (Sja). Residues are highlighted in 
black and grey when they are identical and similar, respectively, between Spd1 and Spd2 
orthologues. Amino acid residues in dark and light blue indicate conservation predominantly in 
Spd1 orthologues, and in dark and light red predominantly in Spd2 orthologues. The Hug domain 
(*) and the Spd domain (**) are boxed. Amino acids defining the Spd1 PIP degron (Q-x-x-L-x-x-x-
x-x-x-x-R) (Salguero et al., 2012) are marked above the aligned sequences. (B) Alignment of Spd2 
with other fungal RNR inhibitors. Identical and similar amino acid residues are highlighted in, 
respectively, black and grey. Hug, Sml, and Rnr1 domains as defined by (Lee et al., 2008) are 
boxed. Spd1 and Spd2 share a unique domain close to the C-terminus, which we termed the Spd 
domain. 
 
Figure 2. Structural properties of Spd2. (A) Spd2 was purified to homogeneity and the 
electrophoretic mobility was investigated by electrophoresis. Lane 1: Marker, Lane 2: Purified 
Spd2. (B) A far-UV CD spectrum of purified Spd2 showing a large negative ellipticity with a 
maximum at 199 nm, suggesting a disordered protein with little or no secondary structure. (C) An 
NMR spectrum of purified Spd2 showing that only a small dispersion of signals was observed in 
the 1H- dimension, further suggesting the protein is disordered with no globular fold. 
 
Figure 3. Overexpression of Spd2 inhibits S phase. (A) Overexpressing either Spd1 or Spd2 leads 
to accumulation of a subset of elongated and aberrant cell shapes. The effect of Spd2 
overexpression is not dependent on a functional spd1+ gene and vice versa. Cells were grown to 
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mid-log phase in minimal media with or without thiamine for 24 hours before pictures were taken. 
Scale bar represents 6 micrometers. (B) Quantification of FACS analysis of cells overexpressing 
Spd1 or Spd2. Cell cycle distribution was analysed according to (Knutsen et al., 2011). “S1” 
represents the fraction of S phase cells with one nucleus, while “S2” represents binucleate cells (as 
defined by the width of the DNA signal) undergoing replication. When overexpressing either Spd1 
or Spd2, the proportion of S phase cells increased, in particular "S1" cells. Representative examples 
of this quantification method are given in Figure S1. 
 
Figure 4. Spd2 is degraded by CRL4Cdt2 during S phase and replication stress. (A) Samples from 
the indicated strains were harvested before and after 4 hours of growth in the presence of 
hydroxyurea (HU) and the Spd2 levels were monitored by Western blotting. Spd2 was degraded 
upon HU-induced replication stress in wild type and Δspd1 cells, but not in CRL4Cdt2-defective 
Δddb1 cells. (B) Wild-type cells were synchronised in G2 by centrifugal elutriation and samples 
were harvested at the indicated time-points. Spd1 and Spd2 levels were monitored by Western 
blotting. The fraction of S-phase cells (Knutsen et al., 2011) peaked at 50% between 80-120 
minutes. Unlike Spd1, Spd2 was not strongly down-regulated at S phase. (C) Samples from the 
indicated strains were harvested before and after 4 hours of growth in the presence of hydroxyurea 
(HU) and Spd1 levels were monitored by Western blotting. Spd1 was degraded upon HU-induced 
replication stress in wild type and Δspd2 cells, but not in Δddb1 cells. A slightly elevated abundance 
of Spd1 was observed in Δspd2 cells. Tubulin was used as loading control in all three panels. A 
molecular weight marker was run alongside samples and marker bands are given by size (kDa). 
 
Figure 5.  Spd2 has a function similar to Spd1 in the damage response. (A) 5-fold serial dilutions of 
the indicated strains were spotted onto control plates or plates containing the indicated 
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concentrations of MMS or zeo (= zeocin, a bleomycin related drug). While the sensitivity of Δddb1 
towards MMS is rescued to the same extend in Δspd1, Δspd2 and Δspd1 Δspd2 mutants cells, zeo 
sensitivity is rescued better by Δspd1 than Δspd2. (B) Spot test on plates containing 6 or 8 mM HU. 
Here, Δspd1 Δspd2 double mutant cells show better rescue of Δddb1 than either single mutant.   
 
Figure 6. Deleting spd2 abolishes RNR FRET, but does not affect Suc22 localisation. (A) In wild-
type cells, CFP-tagged Suc22R2 and YFP-tagged Cdc22R1 give rise to a FRET signal, which is lost 
when either spd1 or spd2 is deleted. (B) The FRET signal is lost in both the nucleus and the 
cytoplasm of Δspd2 cells (error bars reflect SD; n=8-10 cells). (C) Suc22-GFP accumulates in the 
nucleus in wild-type cells. The nuclear localisation was intact in Δspd2 cells, but was abolished in 
Δspd1 and Δspd1Δspd2 cells. Scale bar represents 6 micrometers. 
 
Figure 7. Deleting spd2 partially rescues the meiotic defect and checkpoint dependency of 
CRL4Cdt2 defective cells. (A) Homothallic h90 cells starved for a nitrogen source go through meiosis, 
resulting in the formation of 4-spored asci. Shown are the percentages of zygotes/asci with 0-4 
spores of the various homothallic strains as indicated. In wild-type cells, close to 100% asci are 4-
spored. When components of the CRL4Cdt2 pathway were absent (Δddb1, Δcdt2 or Δcsn1), meiosis 
became defective, resulting almost exclusively in asci without spores. When deleting spd1 in 
CRL4Cdt2 defective cells, the sporulation efficiency was reverted to almost wild-type levels. When 
spd2 was deleted in CRL4Cdt2 defective cells, the sporulation efficiency was only partially rescued. 
However, most spore-containing asci had fewer than four spores. (B) Representative images of 
zygotes/asci of wild type and mutants as indicated. While Δspd1 restored sporulation efficiency of 
Δddb1 cells to almost the wild-type level, Δddb1 Δspd2 mainly produced empty zygotes and asci 
with 2 spores. Scale bar represents 6 micrometers. (C) Cells lacking a functional CRL4Cdt2 pathway 
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require a functional checkpoint for viability. 10-fold serial dilutions of the indicated strains were 
spotted onto YEA and incubated for the indicated number of days.  rad3-TS Δddb1 and rad3-TS 
Δcsn1 cells were unable to grow at the restrictive temperature. Deletion of spd1 largely rescued 
viability, consistent with (Holmberg et al., 2005). Deletion of spd2 caused a partial rescue of 
viability in rad3-TS Δddb1 and rad3-TS Δcsn1 backgrounds. Simultaneous deletion of spd1 and 
spd2 caused full rescue, suggesting that accumulation of both Spd1 and Spd2 can contribute to 
checkpoint activation independently of each other. (D) Cellular dATP/ATP concentrations were 
measured by a primer extension assay as a measure of regulation of overall dNTP pools. Strains 
lacking spd1 had elevated dNTP pools due to deregulation of RNR. However, deleting spd2 did not 
cause elevated dATP pools. P<0.05 for wt vs. Δspd1 and wt vs. Δspd1 Δspd2. 
 
Figure 8. Combining Δspd2 with the cdc22D57N mutation rescues Δddb1 deficiencies to the same 
extent as deleting spd1. (A) Consistent with Figure 7A, Δspd1 rescued the sporulation deficiency of 
an h90 Δddb1 strain almost fully. Both Δspd2 and cdc22D57N rescued the deficiency partially, but 
when combining Δspd2 and cdc22D57N, the sporulation levels were rescued almost fully. (B) Both 
Δspd2 and cdc22D57N rescued the viability of a rad3-TS Δddb1 strain partially, but when combined, 
viability was rescued to a similar extent as by Δspd1. Note that the plates depicted are the same as 
shown in Figure 7C.  
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